119th Congress · introduced in the Senate · Jun 11, 2025
Close the Round-Tripping Loophole Act
Official title from Congress.gov
Latest action (Jun 11, 2025): Read twice and referred to the Committee on Finance.
View on Congress.govPolicy area: Taxation
No official summary has been published for this bill.
Includes amendment, cloture, and procedural votes. Each is labeled with its exact question; only a passage question is a vote to pass the bill.
No recorded roll calls on this bill in coverage.
Read twice and referred to the Committee on Finance.
Introduced in Senate
Actions from Congress.gov, newest first.
LD-2 reports whose issue descriptions explicitly cite this bill (bill type and number validated against Congress.gov records). A citation does not establish the client's position or any contact with a member.
Loading lobbying reportsCoverage: reports for 2025 onward, posted Jan 1, 2025 through Oct 24, 2026.
5 citations.
ELEKTA, INC. · lobbying firm or registrant: ELEKTA, INC.
2025 Q3 report (Jul 1, 2025 – Sep 30, 2025) · posted Jun 30, 2026 · issue area: Medicare/Medicaid
$70,000
Spent on own lobbying
Medicare Reimbursement and general Medicaid issues ROCR, H.R.1031 and S.2021
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
ELEKTA, INC. · lobbying firm or registrant: ELEKTA, INC.
2025 Q4 report (Oct 1, 2025 – Dec 31, 2025) · posted Jun 30, 2026 · issue area: Medicare/Medicaid
$70,000
Spent on own lobbying
ROCR legislation H.R. 1031 and S. 2021 Medicare access Medicare reimbursement General Medicare issues Medicaid access Medicaid reimbursement General Medicaid issues
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
ALLIANCE FOR BIOPHARMACEUTICAL COMPETITIVENESS AND INNOVATION · lobbying firm or registrant: THE WASHINGTON TAX & PUBLIC POLICY GROUP
2025 Q4 report (Oct 1, 2025 – Dec 31, 2025) · posted Jan 13, 2026 · issue area: Taxation/Internal Revenue Code
$70,000
Paid to lobbying firm
…sections 11, 41 and 174, 55, 56A, and 59, 59A, 163(j), 168(k), 250, 951A (H.R. 1990, S. 1639, H.R. 1347, S. 559, S. 1688, H.R. 574, S. 187, H.R. 1062, S. 1605, S. 2021, H.R. 1 - Sections 70301, 70302, 70303, 70321, 70322, 70323, 70331, 70341, 70342, 70361.)
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
ALLIANCE FOR BIOPHARMACEUTICAL COMPETITIVENESS AND INNOVATION · lobbying firm or registrant: THE WASHINGTON TAX & PUBLIC POLICY GROUP
2025 Q3 report (Jul 1, 2025 – Sep 30, 2025) · posted Oct 14, 2025 · issue area: Taxation/Internal Revenue Code
$450,000
Paid to lobbying firm
…ed to IRC sections 11, 41 and 174, 59A, 163(j) 164(a), 168(k), 250, 951A (H.R. 1990, S. 1639, H.R. 1347, S. 559, S. 1688, H.R. 574, S. 187, H.R. 1062, S. 1605, S. 2021, H.R. 1 - Sections 70301, 70302, 70303, 70321, 70322, 70323, 70331, 70341, 70342, 70361.)
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
ALLIANCE FOR BIOPHARMACEUTICAL COMPETITIVENESS AND INNOVATION · lobbying firm or registrant: THE WASHINGTON TAX & PUBLIC POLICY GROUP
2025 Q2 report (Apr 1, 2025 – Jun 30, 2025) · posted Jul 8, 2025 · issue area: Taxation/Internal Revenue Code
$70,000
Paid to lobbying firm
…. and its Territories. Issues related to IRC sections 11, 164(a), 951A, 250, 59A, 163(j), 168(k), 174, and 41. (H.R.1990, H.R. 574, H.R. 1062, S. 187, S. 1605, S. 2021, H.R. 1 - Sections 70301, 70302, 70321, 70322, 70323, 70331, 70361). Issues related to interest deductibility. (H.R. 1347, S. 559, S. 1688, H.R. 1 - Section 70…
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing